Delivery Order SPE2DX15D9312-SPE2DX25FDEBE

Award Date 10/23/24
Potential Completion Date 11/14/24
Potential Value $6.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $17,974.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, with a period of performance through December 9, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $6,468.00 and covers the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $17,415.00 contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a ceiling value of $35,499.60 and a period of performance through June 10, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,177.78, is for the procurement of 4566735277 - PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract has an ultimate completion date of January 3, 2025 and was awarded on December 11, 2024. DMS Pharmaceutical Group Inc. is a key...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,223.68, is for the delivery of 4566275343 - PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $25,800.72 and has an ultimate completion date of January 10, 2025. It is for the provision of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $17,246.88, is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The contract has a completion date of February 23, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDV) with the DLA, contract 4600082013 under the SPE2DB...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,600.00 firm fixed-price delivery order contract is for the provision of 4568061323 ! PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract has an ultimate completion date of May 5, 2025 and was awarded on April 14, 2025. DMS Pharmaceutical Group Inc. holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $35,424.00, is for the delivery of 4,567,231 units of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, by February 27, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
  • SPE2DX15D9312
    Indefinite Delivery Contract
  • SPE2DX15D9312-SPE2DX25FDEBE
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,153.80 contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of November 14, 2024. DMS Pharmaceutical Group Inc. also holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract award is not associated with a specific set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contracts across multiple product categories and medical domains.

Generated 1/22/25, 9:04 AM